Regulation of N-myc expression in development and disease

Cancer Letters

Volumn 180, Issue 2, 2002, Pages 107-119

  Strieder, V ^a   Lutz, W ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Amplification; Apoptosis; Childhood tumor; Chromosome; Gene regulation; Growth factor; N myc; Neuroblastoma; Oncogene; Pediatric cancer; Prognosis; Proliferation; Promoter signaling; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR;

CARCINOGENESIS; CHROMATIN STRUCTURE; DISEASE COURSE; DNA METHYLATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 0037189025     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00020-4     Document Type: Review

References (141)

1. The Myc/Max/Mad network and the transcriptional control of cell behavior
2. Function of the c-myc oncoprotein in chromatin remodeling and transcription
3. Deconstructing myc
4. Amplification of oncogenes revisited: From expression profiling to clinical application
5. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma
6. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
7. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
8. Targeted expression of MYCN causes neuroblastoma in transgenic mice
9. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung
10. N-myc amplification in malignant astrocytoma
11. Expression and amplification of the N-myc gene in primary retinoblastoma
12. Enhanced expression of the N-myc gene in Wilms' tumors
13. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
14. Reversible activation of c-myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
15. Reversible tumorigenesis by MYC in hematopoietic lineages
16. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo
17. Differential expression of myc family genes during murine development
18. Expression of N-myc in teratocarcinoma stem cells and mouse embryos
19. N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization
20. A comparative, analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis
21. Expression of the N-myc proto-oncogene during the early development of Xenopus laevis
22. Organization and expression of the chicken N-myc gene
23. Notch1 is required for the coordinate segmentation of somites
24. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus
25. Defective development of the embryonic liver in N-myc-deficient mice
26. L-myc and N-myc influence lineage determination in the central nervous system
27. The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain
28. Regulation of the neural crest cell fate by N-myc: Promotion of ventral migration and neuronal differentiation
29. Increased expression of the N-myc gene during normal and neoplastic rat liver growth
30. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition
31. Protein phosphorylation required for the formation of E2F complexes regulates N-myc transcription during differentiation of human embryonal carcinoma cells
32. Differential regulation of the N-myc gene in transfected cells and transgenic mice
33. Tissue and age specific expression of the myc proto-oncogene family throughout the life span of the C57BL/6J mouse strain
34. Tumour induction by the retinoblastoma mutation is independent of N-myc expression
35. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene
36. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes
37. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop
38. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung
39. Role of N-myc in the developing mouse kidney
40. Generation of normal lymphocytes derived from N-myc-deficient embryonic stem cells
41. c-myc is a downstream target of Smad pathway
42. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program
43. Molecular requirements for transcriptional initiation of the murine c-myc gene
44. In vivo footprints between the murine c-myc P1 and P2 promoters
45. Three distinct elements within the murine c-myc promoter are required for transcription
46. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements
47. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells
48. Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter
49. MAZ, a zinc finger protein, binds to c-myc and C2 gene sequences regulating transcriptional initiation and termination
50. The human cut homeodomain protein represses transcription from the c-myc promoter
51. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1
52. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene
53. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F
54. Histone deacetylase 1 can repress transcription by binding to Sp1
55. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway
56. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction
57. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes
58. TGF beta 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures
59. pRb is necessary for inhibition of N-myc expression by TGF-beta 1 in embryonic lung organ cultures
60. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains
61. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B
62. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1
63. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1
64. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: Conditional regulation of c-myc transcription by temperature-sensitive v-abl
65. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases
66. Regulation of c-myc expression by PDGF through Rho GTPases
67. Myc but not Fos rescue of PDGF signalling block caused by kinase- inactive Src
68. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta
69. Identification of c-myc as a target of the APC pathway
70. The macromolecular state of the transcription factor E2F and glucocorticoid regulation of c-myc transcription
71. Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways
72. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells
73. c-myc is a critical target for c/EBPalpha in granulopoiesis
74. v-Abl activates c-myc transcription through the E2F site
75. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells
76. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments
77. N-myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells
78. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
79. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells
80. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells
81. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo
82. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation
83. Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions
84. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: Relationship to clinical outcome
85. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells
86. Human N-myc is closely related in organization and nucleotide sequence to c-myc
87. Structure and expression of the murine N-myc gene
88. Localization of regulatory elements controlling human MYCN expression
89. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines
90. Transcriptional down-regulation of N-myc expression during B-cell development
91. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor
92. Transcription factors, normal myeloid development, and leukemia
93. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription
94. HBP1: A HMG box transcriptional repressor that is targeted by the retinoblastoma family
95. N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells
96. Cell type-specific activity of the N-myc promoter in human neuroblastoma cells is mediated by a downstream silencer
97. A novel intron element operates posttranscriptionally to regulate human N-myc expression
98. Role of first exon/intron sequences in the regulation of myc family oncogenic potency
99. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype
100. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes
101. Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver
102. Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer
103. Role of E2F transcription factor in E1A-mediated trans activation of cellular genes
104. Neuroectodermal tumors expressing c-, L-, and N-myc in transgenic mice that carry the E1A/E1B gene of human adenovirus type 12
105. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway
106. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
107. Myc requires distinct e2f activities to induce S phase and apoptosis
108. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis
109. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis
110. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus
111. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals
112. Direct recruitment of N-myc to target gene promoters
113. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
114. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27
115. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1)
116. Differential regulation of the N-myc proto-oncogene by ROR alpha and RVR, two orphan members of the superfamily of nuclear hormone receptors
117. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation
118. Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas
119. Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc
120. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts
121. Post-transcriptional gene silencing by double-stranded RNA
122. Regulation of N-myc gene expression: Use of an adenovirus vector to demonstrate posttranscriptional control
123. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma
124. Binding of a 40-kDa protein to the N-myc 3′-untranslated region correlates with enhanced N-myc expression in human neuroblastoma
125. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts
126. Neuron-specific hel-N1 and HuD as novel molecular markers of neuroblastoma: A correlation of HuD messenger RNA levels with favorable prognostic features
127. N-myc translation is initiated via an internal ribosome entry segment that displays enhanced activity in neuronal cells
128. Transition of localization of the N-myc protein from nucleus to cytoplasm in differentiating neurons
129. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification
130. Human small-cell lung cancers show amplification and expression of the N-myc gene
131. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients
132. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation
133. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines
134. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele-specific expression
135. Genetics of embryonal tumours of childhood: Retinoblastoma, Wilms' tumour and neuroblastoma
136. Myc gene amplification and expression in primary human neuroblastoma
137. MYCN protein expression as a predictor of neuroblastoma prognosis
138. Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gamma
139. Contributions of Myc to tumorigenesis
140. c-myc induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
141. Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cells